Company name:
Amphastar Pharmaceuticals Inc
-
IPO SHARE PRICE:$7.00
-
IPO DATE:June 25, 2014
-
TICKER:AMPH
-
MAIN STOCK EXCHANGE:NASDAQ
-
CURRENT HQ LOCATION:11570 6 Street Rancho Cucamonga CA 91730
-
FISCAL YEAR END:December 31
-
INCORPORATION JURISDICTION:None
-
ORGANIZED AS THE FOLLOWING LEGAL TYPE:Corporation
-
Investor Relations Webpage:Coming soon!
-
TAX RATE:USA federal corporate nominal income tax rate is 21%
Short Description
Amphastar Pharmaceuticals Inc
We are working hard and as soon as possible to provide company description soon. Feel free to reach out to request it sooner: improve@real-clear-investing.com
Statement of Cash Flow
(USD in thousand)
Selected Year:
31-Dec
2020
2020
OPERATING ACTIVITIES
Cash received and spent on operating activites of business — buying materials, paying salaries, receiving payments from clients, etc
24.5% -
Accounts payable and accrued liabilities
24.3% -
Stock-based compensation
24.3% -
Depreciation of property plant and equipment
18.2% -
Inventory
4.3% -
Operating lease right-of-use asset amortization
1.5% -
Reserve for uncertain tax positions
1.3% -
Net income (loss)
1.2% -
Amortization of product rights trademarks and patents
0.3% -
(Gain) loss on assets sale and impairment
SOURCEs
24.3%
4.3%
18.2%
24.5%
24.3%
100 %
0%
USES
68.0%
23.9%
4.3%
23.9% -
Accounts receivable
4.3% -
Operating lease liabilities
2.4% -
Prepaid expenses and other assets
1.2% -
Income tax refunds deposits and payable
0.2% -
Deferred income taxes
|
|
|
|
|
|
|
|
|
|
|
|
---|---|---|---|---|---|---|---|---|---|---|---|
Net income (loss) | ($6,660) | $46,505 | $1,097 | $1,097 | ($23,168) | ||||||
Depreciation and amortization
|
- | - | - | - | - | ||||||
Depreciation of property plant and equipment
|
14,529 | 17,073 | 20,491 | 20,491 | 22,180 | ||||||
Operating lease right-of-use asset amortization
|
- | 3,011 | 3,653 | 3,653 | 3,840 | ||||||
Amortization of product rights trademarks and patents
|
1,987 | 1,037 | 1,036 | 1,036 | 1,060 | ||||||
Stock-based compensation
|
16,680 | 17,295 | 20,498 | 20,498 | 17,332 | ||||||
Imputed interest accretion
|
- | - | - | - | - | ||||||
Deferred income taxes
|
(1,414) | 4,542 | (162) | (162) | (15,200) | ||||||
Asset impairments
|
- | - | - | - | - | ||||||
(Gain) loss on sale of property and equipment
|
- | - | - | - | - | ||||||
(Gain) loss on sale of property plant and equipment
|
- | - | - | - | - | ||||||
(Gain) loss on assets sale and impairment
|
1,429 | 1,036 | 240 | 240 | 316 | ||||||
Reserve for income tax liabilities
|
- | - | - | - | - | ||||||
Reserve for uncertain tax positions
|
(464) | 3,010 | 1,285 | 1,285 | 5,140 | ||||||
Accounts receivable
|
(16,295) | 6,702 | (20,160) | (20,160) | (53,816) | ||||||
Income tax refund and deposits
|
- | - | - | - | - | ||||||
Income tax refunds deposits and payable
|
3,849 | 591 | (972) | (972) | 4,004 | ||||||
Inventory
|
(5,984) | (41,103) | 15,297 | 15,297 | 51,784 | ||||||
Prepaid expenses and other assets
|
1,375 | (3,604) | (2,049) | (2,049) | 6,824 | ||||||
Accounts payable and accrued liabilities
|
29,159 | (11,720) | 20,609 | 20,609 | 51,752 | ||||||
Income tax payable
|
- | - | - | - | - | ||||||
Income tax refund deposits and payable
|
3,849 | 591 | - | - | - | ||||||
Operating lease liabilities
|
- | (2,613) | (3,597) | (3,597) | (4,476) | ||||||
Net cash provided by (used in) operating activities | $38,191 | $41,762 | $57,266 | $57,266 | $67,572 |
Selected Year:
31-Dec
2020
2020
INVESTING ACTIVITIES
Cash spent on acquiring plant, equipment and other businesses, cash recei0 from sale of plant, equipment and subsidiaries as well cash parked temporarily in different securities - government bonds typically
25.4% -
Maturities of marketable securities
SOURCEs
74.6%
25.4%
100 %
0%
USES
69.3%
27.8%
69.3% -
(Purchase and construction) sale of property plant and equipment
27.8% -
Purchases of marketable securities
2.9% -
Deposits and other assets net
|
|
|
|
|
|
|
|
|
|
|
|
---|---|---|---|---|---|---|---|---|---|---|---|
(Increase) decrease in restricted cash and deposits
|
- | - | - | - | - | ||||||
(Purchases) sales of restricted cash and marketable securities
(Purchases) sales of restricted cash and marketable securities
|
- | - | - | - | - | ||||||
(Purchases) sales of restricted marketable securities
|
- | - | - | - | - | ||||||
(Purchases) sales of marketable securities
|
- | - | - | - | - | ||||||
Purchases of marketable securities
|
(308) | (8,815) | (13,557) | (13,557) | (54,228) | ||||||
Maturities of marketable securities
|
91 | - | 12,411 | 12,411 | 45,800 | ||||||
(Purchase) sale of property plant and equipment
|
245 | (41,555) | - | - | - | ||||||
(Purchase and construction) sale of property plant and equipment
(Purchase and construction) sale of property plant and equipment
|
(46,808) | (41,555) | (33,855) | (33,855) | (135,420) | ||||||
Purchase of trademarks and other intangible assets
|
- | - | - | - | - | ||||||
Sale of intangible assets
|
4,400 | - | - | - | - | ||||||
Capitalized labor overhead and interest on self-constructed assets
Capitalized labor overhead and interest on self-constructed assets
|
- | - | - | - | - | ||||||
Acquisition of business net of cash
|
- | - | - | - | - | ||||||
Deposits and other assets net
|
198 | (157) | (1,414) | (1,414) | (2,960) | ||||||
Net cash provided by (used in) investing activities | ($42,182) | ($50,527) | ($36,415) | ($36,415) | ($48,704) |
Selected Year:
31-Dec
2020
2020
FINANCING ACTIVITIES
Items in this group are concerned with borrowing funds, repaying debt, issuing equity, buying back shares, etc.
70.3% -
Proceeds (payments) related to employee stock compensation plans (ESPP)
19.1% -
Long-term borrowing
3.8% -
Borrowing under Revolving Credit Facility
SOURCEs
6.8%
19.1%
3.8%
70.3%
100 %
0%
USES
25.5%
74.2%
74.2% -
Stock repurchases
25.5% -
Repayment of long-term borrowing
0.3% -
Acquisition of additional ownership interest in ANP
|
|
|
|
|
|
|
|
|
|
|
|
---|---|---|---|---|---|---|---|---|---|---|---|
Issuance of common stock
|
- | - | - | - | - | ||||||
Proceeds from the private placement of ANP
|
38,036 | 18,298 | - | - | - | ||||||
Proceeds from issuance of common stock upon exercise of stock options net of withholding taxes
Proceeds from issuance of common stock upon exercise of stock options net of withholding taxes
|
- | - | - | - | - | ||||||
Proceeds (payments) related to employee stock compensation plans (ESPP)
Proceeds (payments) related to employee stock compensation plans (ESPP)
|
8,946 | 3,421 | 23,165 | 23,165 | 7,412 | ||||||
Offering costs
|
- | - | - | - | - | ||||||
Deferred offering costs
|
- | - | - | - | - | ||||||
Borrowing under Revolving Credit Facility
|
347 | - | 1,238 | 1,238 | 664 | ||||||
Repayment of Revolving Credit Facility
|
- | (347) | - | - | - | ||||||
Short-term borrowing (repayment)
|
- | - | - | - | - | ||||||
Long-term borrowing
|
8,431 | 3,570 | 6,283 | 6,283 | 12,864 | ||||||
Repayment of long-term borrowing
|
(5,705) | (6,434) | (8,401) | (8,401) | (8,288) | ||||||
Acquisition of additional ownership interest in ANP
|
- | - | (106) | (106) | - | ||||||
Excess tax benefit from stock-based compensation
|
- | - | - | - | - | ||||||
Stock repurchases
|
(25,047) | (22,291) | (24,425) | (24,425) | (13,560) | ||||||
Repurchases of common stock
|
- | - | - | - | - | ||||||
Net cash provided by (used in) financing activities | $25,008 | ($3,783) | ($2,246) | ($2,246) | ($908) |
Selected Year:
31-Dec
2020
2020
NET CHANGE IN CASH
Grand Total for sum of cash flows coming from operations, investing and financing
$18,957,000
|
|
|
|
|
|
|
|
|
|
|
|
---|---|---|---|---|---|---|---|---|---|---|---|
Cash and equivalents - Beginning of period | $67,459 | $88,202 | $75,550 | - | $359,100 | ||||||
Effect of changes in foreign exchange rates on cash | (274) | (104) | 352 | - | 968 | ||||||
(Decrease) increase in cash and cash equivalents | 20,743 | (12,652) | 18,957 | - | 18,928 | ||||||
Cash and equivalents - End of period | $88,202 | $75,550 | $94,507 | - | $378,028 |